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Patterns of childhood cancer among siblings
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Summary The National Registry of Childhood Tumours contains over 51 000 records of children born in
Great Britain who developed cancer under the age of 15 years. Patterns of childhood cancer among families
containing more than one child with cancer have been studied. A total of 225 'sib pair' families have been
ascertained from interviews with parents of affected children, from hospital and general practitioner records
and from manual and computer searches of names and addresses of patients. A number of special groups have
been identified, including those with a known genetic aetiology such as retinoblastoma, twins and families with
three or more affected children. A further 148 families not in any of the above groups contain two children
with cancer: in 46 families the children had tumours of the same type, most commonly leukaemia. Some of the
families are examples of the Li-Fraumeni syndrome; some are associated with other conditions, including
Down's syndrome. There is clearly a genetic element in the aetiology of cancer in some families discussed here;
shared exposure to environmental causes may account for others and some will be simply due to chance.
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The aetiology of most childhood cancers is still little
understood; a small proportion of neoplasms in children
are easily recognised as being genetically determined but for
most cases of childhood cancer there is no family history of
cancer or genetic disease. There are, however, well-
documented associations with a number of single-gene
conditions such as neurofibromatosis, tuberous sclerosis,
Fanconi's anaemia and ataxia telangiectasia, and with
genetic conditions such as Down's syndrome (Mulvihill,
1982). The most striking, and one of the most studied,
examples of a hereditary cancer is retinoblastoma, a disease
of early childhood. About 40% of all cases in Britain and
other developed countries follow the pattern of an autosomal
dominant condition, but the 'retinoblastoma gene' is in fact a
tumour-suppressor gene. Knudson and Strong (1972a,b,)
suggested that two other childhood tumours, Wilms' tumour
and neuroblastoma, have a similar genetic aetiology but it
now appears that the proportions of hereditary cases for
these two diagnoses are much smaller than was originally
suggested.
In some families two or more siblings develop cancer or
leukaemia in childhood. Some of these are accounted for by
hereditary retinoblastoma and some by familial aggregations
of cases arising from association with known genetic
disorders. The only two systematic, population-based studies
of the occurrence of childhood cancer among siblings are
those by Miller (1971) in the United States and by Draper et
al. (1977) in Great Britain. Both of these, together with two
large hospital-based series (Li et al., 1976; Green, 1986) and a
considerable number of case reports of familial aggregations,
suggest that, in addition to cases occurring in families where
there is a known genetic disease, there is a small increased
risk among the siblings ofchildren with cancer. Some of these
families are examples of the Li-Fraumeni syndrome (Li and
Fraumeni 1969, Li et al., 1988); some may be associated with
hitherto unidentified syndromes; some, perhaps about half,
are due to chance. In this paper we examine the patterns of
neoplasms in families in which more than one child has
cancer. The results presented here update those in Draper et
al. (1977); the period covered and the number of cases are
about double that of the earlier paper. For genetic
counselling, estimates of risks to sibs of affected children
are needed and in a subsequent paper we shall use these data
to estimate such risks.
Patients and methods
The Childhood Cancer Research Group (CCRG) maintains
the National Registry of Childhood Tumours (NRCT)
covering England, Scotland and Wales. This includes cancer
registrations (malignant neoplasms and any brain tumours)
from 1962 onwards for children under the age of 15 years,
and death certificates giving a neoplasm as a cause of death
from 1953 onwards where this occurs below the age of 20
years (Stiller et al., 1995). The great majority of cases of
childhood cancer diagnosed between 1953 and 1993 are
included. In addition, the registry includes records from
certain hospitals of children diagnosed with cancer before
1962 who survived at least 3 years. The results in this paper
are based on a total of about 51 000 cases; we have tried to
identify cases born in Britain and diagnosed before 1993 and
who had a sibling with cancer also diagnosed before 1993.
Information about the families of children with cancer has
been obtained from hospital and general practitioner records
and from interviews with the parents of children included in
the Oxford Survey of Childhood Cancers, a national case-
control study covering deaths from childhood cancer for a
period of about 30 years from 1953 onwards (Stewart et al.,
1958). Many of the families reported here were identified
during these interviews, some from information in hospital
records, and others from manual and computer searches
comparing names and addresses. Half-siblings have been
included with full siblings.
A total of 225 such families (463 children) have been
ascertained in these ways. The information on these families
is summarised in Table I; two of the categories listed (those
for which there is a known genetic disease associated with the
cancers and those in which three or four children are
affected) include a few cases diagnosed at age 15 or above
as these families are of particular interest. Of the 414
probands, or index cases, i.e. those notified to the NRCT
through the procedures described above, we have confirmed
the diagnosis from hospital records in 400 cases. For 84% of
the probands the pathology record or an abstract of it was
available, although pathological review has been carried out
in relatively few cases. Among the 49 non-probands, i.e.
patients ascertained not through the NRCT procedures but
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Table I 'Sib pair' families in the National Registry of Childhood Tumours
Probands Others
Diagnosis Diagnosis
Category of Diagnosis not Diagnosis not
family Families Children confirmed a confirmed confirmed a confirmed
Hereditary 48 101 84 2 1 14
retinoblastoma
Neurofibromatosis with 8 17 14 3 0 0
malignant tumour
Other neoplasms with 9 20 13 1 0 6
known genetic originb
Families with three 6 19 12 0 3 4
or four affected
childrenb
Families with two 155 310 278 8 14 10
affected childrenc
(excluding those neoplasms
with known genetic origin)
Total 225 463 400 14 18 31
aThe great majority of diagnoses were confirmed through hospital records, usually with confirmation through
pathology (see text). "One family of four children with multiple endocrine neoplasia appears twice in the table.
cIncluding twins.
only through a sibling who was an index case, the diagnosis
was confirmed from hospital records in 18 cases, and for 15
of these a pathology record was obtained; for 31 patients,
hospital records were not available, but these included 14
patients with hereditary retinoblastoma, most of whom were
diagnosed before 1962 and for whom the family history left
no doubt over diagnosis, and eight other patients for whom
death certificates were obtained.
Children with retinoblastoma and other known genetic
diseases have been studied separately from the main group.
Several other groups of particular interest are also discussed
separately: twins with both children affected, families in
which one or more of the affected sibs has a double primary
tumour and cases with one or more sibs affected by some
other disease or syndrome.
We have also considered certain combinations of tumours
that appear in 'cancer families'. In defining these families we
have used information about cancer and other diseases in
relatives of the sib pairs in the NRCT, although such
information is not routinely available to us.
Results
Cancers with a known genetic aetiology
Retinoblastoma The National Registry of Childhood Tu-
mours includes 48 families with two or more siblings with
retinoblastoma. In five of these families the pairs of children
are twins ofthe same sex. Among unilateral sporadic (assumed
non-hereditary) cases of retinoblastoma, five children have
siblings with a different cancer. In two cases this is leukaemia,
in two a brain tumour and in the fifth, osteosarcoma. This
group of cases has been included among the families with two
sibs with cancer and no known genetic aetiology and is
considered in more detail with the other sib pairs below.
Neurofibromatosis The NRCT includes seven families with
neurofibromatosis 1 (NF-1), in each of which two children
under the age of 15 also had a cancer. Eight children
developed an optic nerve glioma; one pair were monozygotic
twins. Other cancers found in conjucntion with NF-l were
oligodendroglioma, glioblastoma, non-Hodgkin lymphoma,
Wilms' tumour and lymphoid leukaemia. Neurofibrosarcoma,
the most common malignancy found in older NF-1 patients,
occurred in only one of these families. In one further family
with three children with NF-1 and cancer, which was also
included in a study of neurofibromatosis and childhood
leukaemia/lymphoma by Stiller et al. (1994), all three children
were registered with T-cell NHL; one of these died of acute
lymphoid leukaemia.
Other genetic conditions A number of other genetically
determined conditions are known to carry an increased risk
of childhood cancer. The registry contains at least nine such
families in which two or more children have cancer. In one
family in which two children developed lymphomas each was
diagnosed with ataxia telangiectasia, an autosomal recessive
condition in which affected individuals are known to have an
increased risk of lymphomas and lymphoid leukaemia. In
another family, one child was diagnosed with acute myeloid
leukaemia and a second child with benign hepatoma: these
children both had Fanconi's anaemia, which is known to
predispose towards these conditions. In two families with
xeroderma pigmentosum, all four children developed
squamous cell carcinoma. In three families, patients were
recorded as having Turcot's syndrome (malignant CNS
tumours associated with familial polyposis), another condi-
tion showing a genetic predisposition to cancer. In the first of
these, one individual with familial polyposis died of a brain
tumour aged 17 years and the sibling was diagnosed with
adenocarcinoma of the colon. In the second, a patient with
polyposis had double primary tumours, adenocarcinoma of
the caecum and lymphosarcoma; the sibling died of
glioblastoma and was described as having pigmented naevi
and haemangioma. In the third, a patient with polyposis coli
developed adenocarcinoma of the bowel and subsequently a
malignant astrocytoma; the sibling died of a brain tumour
aged 5 years. The rare recessive condition of tyrosinosis was
reported in one sib pair family: both children developed
hepatomas. One family, in which four children and their
father had medullary carcinoma of the thyroid, is an example
of multiple endocrine neoplasia, an autosomal dominant
inherited cancer syndrome.
Twins
Among the sib pairs are 12 families in which the affected
children are twins and one family in which two children from
trizygotic triplets developed retinoblastoma. One pair of
retinoblastoma twins is dizygotic, all other twin pairs are
monozygotic. Table II shows the diagnoses for twins and for
sib pairs in which the two tumours are classified as being in
the same histological category.
Families with three orfour sibs affected
Table III shows the six families in which more than two
children developed cancer, excluding those with retinoblasto-
ma and neurofibromatosis. The family with four children
affected by medullary carcinoma of the thyroid has also been
included among the cancers with a known genetic originPatterns of childhood cancer among siblings 9 GJ Draper et al
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Table H Twin pairs and other sib pairs in which both tumours are in the same histological category
Neoplasm Number oftwinpairs Comments Otherfamilies Comments
Lymphoid leukaemia
Acute undifferentiated leukae-
mia
Wilms' tumour
Medulloblastoma
Astrocytoma
Oligodendroglioma
Spinal and cerebral meningioma
Optic nerve glioma
Neuroblastoma
Rhabdomyosarcoma
Non-Hodgkin lymphoma
Gonadal germ cell tumour
Squamous cell carcinoma
Retinoblastoma
3
0
0
0 1
0
0
0
0
0
5b
5
0
Each child had
hypospadias
One child had
cafe au lait spots
Neurofibromatosis
Three pairs
monozygotic
5
3
2
0
0
1
3
2
2
I
2
43
Neurofibromatosis
aIn one pair each child had an extra finger. In a second pair each child had an extra chromosome. bIncludes two
affected children in a set oftriplets.
Table III Families having three or four children with neoplasms
Family Age at diag- Cancer in other
number Diagnosis Sex nosis (years) relatives
3a Retroperitoneal sarcoma M 2
Lymphosarcoma M 2
Lymphoid leukaemia M 5
27a Embryonic renal neoplasm M 2b
Retroperitoneal sarcoma M 2b
Neuroblastoma M 2b
101a Retroperitoneal sarcoma F 0
Embryonic abdominal sarcoma M 4
Lymphoid leukaemia M 14
213a Medulloblastoma M 3 Mother
Carcinoma adrenal cortex F 2 breast cancer
Rhabdomyosarcoma + M 3
chondrosarcoma 16
31ia Lymphoid leukaemia M 2
T-cell NHL F 3
Osteosarcoma + M 2
T-cell NHL 9
384 Medullary carcinoma thyroid F 14 Father same
Medullary carcinoma thyroid F - tumour
Medullary carcinoma thyroid M
Medullary carcinoma thyroid M
aLi-Fraumeni family. bAge at death; age at diagnosis unknown.
mentioned above. The other five families have been classified
as having the Li-Fraumeni syndrome; this syndrome is
discussed later.
Families with two sibs affected
When families with more than two affected children, twins
and those in which the cancer had a known genetic origin
have been excluded, 148 families (296 children) remain. Table
IV shows the diagnoses of the cancer within these families
using the classification for children's tumours given, e.g. in
Stiller et al. (1995); most childhood tumours classified as
'sympathetic nervous system tumours' or 'kidney tumours',
and all of these in this table, are in fact neuroblastomas or
Wilms' tumours respectively. For 85% of the patients there
was histological or haematological confirmation of the
tumour type, 5% of other tumours were confirmed by
radiology and 4% by other clinical diagnosis. Concordance
for tumour type as categorised in Table IV occurred in 46
families or 31% of the total.
If we include twins, there were 34 families, other than
those with retinoblastoma, in which the two children had the
same histological category of neoplasm; these have been
shown in Table II. The most common type was lymphoid
leukaemia (at the time of diagnosis this may have been
described as lymphoblastic or lymphatic leukaemia but the
term lymphoid leukaemia has been used throughout this
paper), in eight families including three with monozygotic
twins.
In six families both children developed Wilms' tumour:
only one of these tumours was bilateral. The children in one
family were monozygotic twins. In another of the families in
which the sibs both had Wilms' tumour the mother was a
survivor from Wilms' tumour in infancy. This family has
been studied by Baird et al. (1994) who were unable to
identify the chromosomal location of the genetic event
associated with the familial tumour.
Among 20 other families in which the two children had
tumours in the same histological category, there were four
pairs of twins. Three pairs of sibs had neuroblastoma, two
astrocytoma, three medulloblastoma and two rhabdomyo-
sarcoma.Patterns of childhood cancer among siblings
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Table IV Families having two children with cancer excluding twins and cancer with a known genetic origin
Soft Other
Tumour group Leukaemia Lymphoma CNS SNS RBL Kidney Liver Bone tissue Germ cell ACC malignant
Leukaemia 17 12 15 4 2 5 1 3 4 2 3
Lymphomas 3 7 3 1 1
Brain and spinal 13 5 2 3 3 8 2 2
(CNS)
Sympathetic nervous 3 1 1
system (SNS)
Retinoblastoma 1
(RBL)
(non-familial)
Kidney tumours 5 3 1
Liver tumours 1
Bone sarcomas 1
Soft-tissue sarcomas 3 1 2
Germ-cell neoplasms 2
Adrenocortical
carcinoma (ACC) 1
Double primary neoplasms The best known of these is Down's syndrome. Two
families in which both children had leukaemia show the
It is well recognised that particular combinations of tumours association of Down's and leukaemia in one sibling. A third
reflecting a genetic predisposition may occur either in family includes a patient with Down's syndrome who was
different family members or in one individual. In the present diagnosed with a fibrosarcoma of the tibia. Her sister, who
series these events have occurred together. In Table V we list had a clinical and radiological diagnosis of osteosarcoma of
the 21 patients in the series who are so far known to have the femur, was mentally retarded and noted as being spastic
developed second primary neoplasms; in three families, two and microcephalic. This again suggests the occurrence of
of them being retinoblastoma families, there were two some genetic syndrome in the family, particularly since the
patients with double primaries. The largest group consisted registry records only 14 cases of Down's syndrome associated
of patients with hereditary retinoblastoma; five such patients, with neoplasms other than leukaemia. (This may be a
including two sisters, developed osteosarcoma. Three families considerable under-recording, but is probably not sufficient
show the well-known association of colorectal cancer with to affect the argument here.)
brain tumours in either the same individual or a sibling. Four Three families have children with hypospadias. This
other families known to be examples of Li-Fraumeni condition is often reported in conjunction with Wilms'
syndrome are described later. tumour; in family 39 both children had Wilms' tumour and
hypospadias, in family 89 a child with hereditary retino-
Associated conditions blastoma had the condition. It is of interest that in family
265, in which the children had Wilms' tumour and
We have already discussed a number of known single-gene medulloblastoma, it is the child with medulloblastoma who
conditions predisposing to childhood cancer. In addition, had hypospadias. In family 270 three girls were reported to
certain syndromes occurring in one or both of the children in have gonadal dysgenesis, two of the children developed
the sib pair families are shown in Table VI. cancer, a gonadoblastoma and a yolk sac tumour. This
Table V Double primary tumours in sib pair families
Family number Neoplasms in index case Neoplasms in sibs
224 Retinoblastoma + osteosarcoma Retinoblastoma + osteosarcoma
58 Retinoblastoma + osteosarcoma Retinoblastoma
106 Retinoblastoma + osteosarcoma Retinoblastoma
118 Retinoblastoma + osteosarcoma Retinoblastoma
280 Retinoblastoma + liposarcoma Retinoblastoma
123a Retinoblastoma + basal cell carcinoma (1) Retinoblastoma + bronchial carcinoma + breast
carcinoma
(2) Retinoblastoma
90 Retinoblastoma + spindle cell sarcoma Retinoblastoma
329 Retinoblastoma + malignant melanoma Retinoblastoma
313 Adenocarcinoma colon + astrocytoma Cerebral tumour
289 Astrocytoma + adenocarcinoma caecum Ependymoma
293 Adenocarcinoma caecum + non-Hodgkin lymphoma Astrocytoma
300b Lymphoid leukaemia + osteosarcoma Lymphoid leukaemia
213a,b Rhabdomyosarcoma + chondrosarcoma (1) Adrenal cortical carcinoma
(2) Medulloblastoma
363 Rhabdomyosarcoma + ganglioneuroblastoma Wilms' tumour
359 Rhabdomyosarcoma + osteosarcoma Ependymoma
31 1ab Osteosarcoma + non-Hodgkin lymphoma (1) Lymphoid leukaemia
(2) non-Hodgkin lymphoma
227b Adrenal cortical carcinoma + rhabdomyosarcoma Rhabdomyosarcoma
102 Squamous cell carcinoma + basal cell carcinoma Squamous cell carcinoma + angiosarcoma
aFamilies including three children with cancer.bLi-Fraumeni family (see text).Patterns of childhood cancer among siblings $0 GJ Draper et al
156
family has been reported by Mann et al. (1983). Family 363
illustrates another chromosome abnormality: XYY syn-
drome. The affected child who had a condition resembling
ataxia telangiectasia was diagnosed with Wilms' tumour. The
sibling of this patient developed two primary tumours,
rhabdomyosarcoma and ganglioneuroblastoma. One patient
with Ollier's disease developed a granulosa cell tumour of the
ovary.
Conditions not known to be associated with childhood
cancer, and possibly due to chance occur in the last two
families in Table VI: sickle-cell anaemia in a patient with
acute lymphoid leukaemia, and Ehlers-Danlos syndrome in
a patient with granulomatous thymoma.
Cancerfamilies
A number of families in the sib pair series are of interest
because ofparticular combinations of tumours in the children
associated with cancer in relatives. These families are shown
in Table VII. There are at least ten families in the sib pair
series that may be examples of the Li-Fraumeni syndrome
(LFS), six in this table, four others in Table III. Four of the
children in Table VII had more than one primary tumour. It
is likely that other sib pairs could be categorised as LFS cases
but we do not routinely receive information about cancer in
the relatives. One of the most remarkable features of Table
VII is the fact that of the 25 tumours mentioned as occurring
in the children, counting double primaries twice, no fewer
than five are adrenocortical cancers. Four of them are in
children classified as Li -Fraumeni families. The tumour
accounts for only about 1 in 500 of all childhood cancers.
Discussion
Little is known about the aetiology of childhood cancer, and
this makes it difficult to interpret the family data presented
here. The occurrence of cancer in multiple members of a
Table VI Other conditions in sib pairs
Neoplasm
Family number Condition First sib Second sib
Previously reported
8 Down's syndrome Myeloid leukaemia Acute leukaemia
322 Down's syndrome Lymphoid leukaemia Lymphoid leukaemia
248 Down's syndrome Fibrosarcoma Osteosarcoma
39 Hypospadias Wilms' tumour Wilns' tumour
89 Hypospadias Retinoblastoma Retinoblastoma
265 Hypospadias Medulloblastoma Wilms' tumour
(Fallot's tetralogy and
genital defects)
270 Gonadal dysgenesis Gonadoblastoma Yolk sac tumour
363 XYY syndrome Wilms' tumour Rhabdomyosarcoma +
ganglioneuroblastoma
330 Ollier's disease Granulosa cell tumour Wilms' tumour
ovary
Previously unreported
296 Sickle cell anaemia Lymphoid leukaemia Hodgkin's disease
253 Ehlers-Danlos syndrome Granulomatous thymoma Medulloblastoma
Patients with neoplasm underlined are those in whom the syndrome is present.
Table VII Cancer families
Family number Child Sex Diagnosis Cancer in relatives
95 1 F Medulloblastoma Mother: breast cancer aged 36
2 M Lymphosarcoma Maternal aunt: cancer aged 37
Maternal grandmother: cancer stomach
213a 1 M Medulloblastoma Mother: adenocarcinoma breast aged 33
2 F Carcinoma adrenal cortex Paternal grandfather: gastric carcinoma aged 66
3 M Rhabdomyosarcoma + chondrosarcoma
227a 1 M Carcinoma of adrenal cortex + rhabdomyosarcoma Mother: bilateral breast cancer aged 30+
2 M Rhabdomyosarcoma
297a I F Carcinoma adrenal cortex Mother: breast cancer aged 27
2 M Rhabdomyosarcoma
424a I M Rhabdomyosarcoma Mother: breast cancer aged 33
2 F Osteosarcoma
40 1 F Carcinoma adrenal cortex Father: lung cancer aged 49
2 F Malignant melanoma Paternal aunt: lung cancer aged 44
Paternal grandmother: cancer
200a 1 F Carcinoma adrenal cortex Father: chondrosarcoma aged 25
2 M Neuroblastoma Maternal grandmother: cancer liver
300a 1 F Lymphoid leukaemia Mother: breast cancer aged 41 and sarcoma
2 F Lymphoid leukaemia + osteosarcoma uterus aged 50
Maternal uncle: chondrosarcoma aged 16
Maternal uncle: glioma aged 21
357 1 M Medulloblastoma Maternal grandmother: breast cancer
2 M Rhabdomyosarcoma
359 1 F Rhabdomyosarcoma + osteosarcoma Father: cancer bladder (no record of age)
2 M Ependymoma
aLi-Fraumeni families.Patterns of childhood cancer among siblings
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family can sometimes be accounted for by the existence of a
known genetic condition predisposing to cancer. In other
families, however, the pattern of familial cancer might be
attributable either to currently unrecognised cancer family
syndromes or to exposure of family members to a common
environmental hazard, or simply be due to chance. Miller
(1971) and Draper et al. (1977) have shown that the number
of families in which two children are affected is too great to
be accounted for by chance, and from the latter paper it
appears that the excess cannot obviously be explained by
association with known genetic disease. The only well-
documented causes of childhood cancer are ionising
radiation (particularly antenatal X-rays; see, for example,
Bithell and Stewart, 1975) and exposure to certain drugs
(mainly chemotherapy used for an earlier cancer, and
diethylstilboestrol in utero, although cancers due to the
latter occur mainly in adolescent girls and young women).
There is no evidence that the observed excess of sib pairs
could be attributable to exposure of both children to ante-
natal X-rays.
Explanations in terms of genetics and environment are not
of course mutually exclusive: a common genetic background
may mean that several members of some families have an
increased susceptibility to environmental factors.
The genetic element in the aetiology of childhood cancer
manifests itself in a variety of ways. In addition to familial
neoplasms such as retinoblastoma and neurofibromatosis,
hereditary diseases predisposing to childhood cancer observed
in families reported here include disorders of chromosome
stability inherited as autosomal recessives, such as xeroderma
pigmentosum, ataxia telangiectasia and Fanconi's anaemia.
Other conditions observed in these families are Turcot's
syndrome, tyrosinosis and medullary carcinoma of the
thyroid. These cases are of interest and importance in
understanding the aetiology of childhood cancer, although
such recognised genetic conditions account for rather a small
proportion of the total cases occurring in childhood.
There are two aetiologically distinct types of retinoblasto-
ma, and perhaps of some other childhood tumours. Over
40% of all cases of retinoblastoma are hereditary and
conform to an autosomal dominant pattern of inheritance.
Such tumours tend to appear at an earlier age than the
sporadic, non-hereditary type and there is an increased
incidence of multiple primaries. Tumours develop when
both normal copies of the relevant gene are mutated or
deleted, (Knudson, 1978). Draper et al. (1992) estimated the
risk of retinoblastoma in sibs of affected patients. For the five
families in which one child has unilateral retinoblastoma and
a second a different type of tumour there was no family
history of the disease; these sib pairs could result from
unrecognised familial retinoblastoma, since it is known that a
wide variety of tumours may occur in individuals carrying the
retinoblastoma gene (Sanders et al., 1989; Eng et al., 1993).
Alternatively some or all of these sib pairs may have arisen
purely by chance as there are in the registry around 950 cases
of presumed non-hereditary retinoblastoma and one might
expect about three malignant tumours among their siblings
simply on the basis of the normal population rate for these
conditions.
For Wilms' tumour, Knudson and Strong (1972a)
suggested a two-stage genetic model similar to that for
retinoblastoma. In the six families in which two children had
Wilms' tumour, only one of the children had bilateral
tumours and the age distribution was similar to that for
Wilms' tumour generally; this contrasts with the findings in
retinoblastoma. In the United States National Wilms'
Tumour Study, 37 out of 3442 cases (1.1%) were found to
be familial; they had none of the features associated with
genetic tumours (Breslow et al., 1988).
In three families both children were diagnosed with
neuroblastoma. Knudson and Strong (1972b) again postu-
lated a two-stage genetic model for neuroblastoma similar to
that for retinoblastoma. However, records from the CCRG
show that the risk for a sibling of a neuroblastoma patient of
developing the same cancer is of the order of 1 per 1000; this
figure implies that only a very small proportion of cases are
transmitted from a parent, i.e. that either the proportion of
parents with germ-cell mutations is low (because the
mutation rate is low or because survival of such potential
parents is low) or that the manifestation rate (penetrance) of
potential genetic cases is low.
Thus, for both Wilms' tumour and neuroblastoma the
hereditary element appears to be much smaller than
originally suggested by Knudson and Strong.
A considerable number of case reports has been published
relating to childhood cancer in twins, but there are only two
or three population-based studies from which concordance
rates can be derived; even these yield estimates only for
leukaemia. The NRCT contains a total ofabout 800 twins, of
which about 240 are monozygotic. Thus, the great majority
of twin pairs are not concordant for childhood cancer. For
leukaemia there is a high concordance rate in monozygous
twins, as suggested by the data in Table II, for cases
diagnosed at an early age. For these cases the proband
concordance rate, i.e. the risk to the co-twin, may be as high
as 25%. In many, or perhaps most, of these cases the
concordance appears to arise not from genetic similarity but
from an in utero transfer of transformed cells from one fetus
to the other (Chaganti et al., 1979; Ford et al., 1993). For
hereditary retinoblastoma the proband concordance rate for
monozygous twins can be directly calculated from the
accepted penetrance of 90% as being 90-100%, depending
on whether one assumes that the probabilities of the twins
being affected are independent or, on the other hand, that if
one is affected the other is more likely to be affected also. For
other diagnostic groups there is no adequate evidence on
which to base an estimate, although it appears likely that
there is an increased risk for monozygous co-twins of affected
children.
Children with Down's syndrome have 10-20 times the
usual risk of leukaemia (Miller, 1963). In the NRCT 291
patients have been identified with Down's syndrome,
although the diagnosis was not routinely verified by
chromosome studies; the great majority, 277 (95%), of these
patients were diagnosed with leukaemia. The family in this
study that included one child with Down's syndrome and
fibrosarcoma and a second child with osteosarcoma and
congenital defects may represent an unidentified syndrome.
Down's and some other syndromes found in families in
this study - hypospadias, gonadal dysgenesis, XYY syndrome
and Ollier's disease - are known to be associated with cancer
(McKusick, 1992). Sickle-cell anaemia and Ehlers-Danlos
syndrome were noted in two other families. These are among
autosomal dominant phenotypes listed by McKusick, but
have not previously been linked with neoplasms.
A genetic element is clearly present in about a third of the
'sib pair' families in this study. For the remainder no clear
pattern emerges; some may be caused by an unknown genetic
predisposition, and some by a shared environmental
exposure; some are undoubtedly due to chance. Diagnosis
of cancer in three or more siblings almost certainly indicates
some genetic susceptibility or immunological deficiency.
The main conclusion to be drawn from this study is that,
except for cases associated with known genetic disease, the
risk of cancer in the sibs of affected children is small: the
current estimate of a doubling of the usual risk, i.e. from
about 1 in 600 to 1 in 300, seems to be consistent with the
results presented here. The main exception to this is the
considerably higher risk of leukaemia for monozygous co-
twins of children with leukaemia.
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